Q3 2015 Newsletter (Issue 11) now available

In this issue: We announce the continued expansion of the BIONET portfolio with co-marketing agreements with Cancer Research Technology (Ximbio) and Liverpool ChiroChem BIONET releases New 5-trifluoromethyl-2,3-disubstituted…